[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2004035819A8 - Oligonucleotide analogues for detecting and analyzing nucleic acids - Google Patents

Oligonucleotide analogues for detecting and analyzing nucleic acids

Info

Publication number
WO2004035819A8
WO2004035819A8 PCT/DK2003/000715 DK0300715W WO2004035819A8 WO 2004035819 A8 WO2004035819 A8 WO 2004035819A8 DK 0300715 W DK0300715 W DK 0300715W WO 2004035819 A8 WO2004035819 A8 WO 2004035819A8
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
detecting
oligonucleotide analogues
analyzing nucleic
nucleic acid
Prior art date
Application number
PCT/DK2003/000715
Other languages
French (fr)
Other versions
WO2004035819A3 (en
WO2004035819A2 (en
Inventor
Sakari Kauppinen
Carsten Alsbo
Peter Stein Nielsen
Daniel Charlton Jeffares
Tobias Mourier
Soeren Moerk
Peter Arctander
Niels Tommerup
Niels Tolstrup
Henrik Vissing
Original Assignee
Exiqon As
Sakari Kauppinen
Carsten Alsbo
Peter Stein Nielsen
Daniel Charlton Jeffares
Tobias Mourier
Soeren Moerk
Peter Arctander
Niels Tommerup
Niels Tolstrup
Henrik Vissing
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exiqon As, Sakari Kauppinen, Carsten Alsbo, Peter Stein Nielsen, Daniel Charlton Jeffares, Tobias Mourier, Soeren Moerk, Peter Arctander, Niels Tommerup, Niels Tolstrup, Henrik Vissing filed Critical Exiqon As
Priority to AU2003273778A priority Critical patent/AU2003273778A1/en
Priority to EP03757735A priority patent/EP1556510A2/en
Publication of WO2004035819A2 publication Critical patent/WO2004035819A2/en
Publication of WO2004035819A3 publication Critical patent/WO2004035819A3/en
Publication of WO2004035819A8 publication Critical patent/WO2004035819A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention features improved non-naturally occurring nucleic acids with higher melting temperature than control nucleic acid with 2’ deoxynukleotides, and methods for expression profiling of mRNAs, identifying and profiling of particular mRNA splice variants, and detecting mutations, deletions, or duplications of particular exons or other splice variants, e.g., alterations associated with a disease such as cancer, in a nucleic acid sample, e.g., a biological sample or a patient sample.
PCT/DK2003/000715 2002-10-21 2003-10-21 Oligonucleotide analogues for detecting and analyzing nucleic acids WO2004035819A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2003273778A AU2003273778A1 (en) 2002-10-21 2003-10-21 Oligonucleotide analogues for detecting and analyzing nucleic acids
EP03757735A EP1556510A2 (en) 2002-10-21 2003-10-21 Oligonucleotide analogues for detecting and analyzing nucleic acids

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42027802P 2002-10-21 2002-10-21
US60/420,278 2002-10-21
DKPA200300752 2003-05-19
DKPA200300752 2003-05-19

Publications (3)

Publication Number Publication Date
WO2004035819A2 WO2004035819A2 (en) 2004-04-29
WO2004035819A3 WO2004035819A3 (en) 2004-08-26
WO2004035819A8 true WO2004035819A8 (en) 2004-09-30

Family

ID=32109043

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2003/000715 WO2004035819A2 (en) 2002-10-21 2003-10-21 Oligonucleotide analogues for detecting and analyzing nucleic acids

Country Status (3)

Country Link
EP (1) EP1556510A2 (en)
AU (1) AU2003273778A1 (en)
WO (1) WO2004035819A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9273312B2 (en) 2007-09-19 2016-03-01 Applied Biosystems, Llc SiRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1576192B1 (en) 2002-12-23 2014-10-29 Agilent Technologies, Inc. Comparative genomic hybridization assays using immobilized oligonucleotide features and compositions for practicing the same
US8321138B2 (en) 2005-07-29 2012-11-27 Agilent Technologies, Inc. Method of characterizing quality of hybridized CGH arrays
WO2006076025A2 (en) * 2004-05-14 2006-07-20 Amaox, Inc. Immune cell biosensors and methods of using same
US20080261258A1 (en) * 2004-07-09 2008-10-23 Amaox, Inc. Immune Cell Biosensors and Methods of Using Same
WO2008111908A1 (en) * 2007-03-15 2008-09-18 Jyoti Chattopadhyaya Five- and six-membered conformationally locked 2',4'- carbocyclic ribo-thymidines for the treatment of infections and cancer
CN103517990A (en) 2010-10-07 2014-01-15 通用医疗公司 Biomarkers of cancer
US8273235B2 (en) 2010-11-05 2012-09-25 Roshan V Chapaneri Dark colored chromium based electrodeposits
KR101598398B1 (en) * 2014-01-08 2016-02-29 (주)제노텍 Mutant Detection Method by Real-Time Polymerase Chain Reaction using selective working of 5'-flap endonuclease activity
WO2015200697A1 (en) * 2014-06-25 2015-12-30 The General Hospital Corporation Targeting human satellite ii (hsatii)
WO2018155451A1 (en) 2017-02-21 2018-08-30 国立大学法人大阪大学 Nucleic acid compound and oligonucleotide
BR112020016524A2 (en) 2018-02-14 2021-09-28 Deep Genomics Incorporated OLIGONUCLEOTIDE THERAPY FOR WILSON'S DISEASE

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014226A2 (en) * 1997-09-12 1999-03-25 Exiqon A/S Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
AU2001257239A1 (en) * 2000-04-25 2001-11-07 Affymetrix, Inc. Methods for monitoring the expression of alternatively spliced genes
WO2002061387A2 (en) * 2000-10-25 2002-08-08 Exiqon A/S Open substrate platforms suitable for analysis of biomolecules

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9273312B2 (en) 2007-09-19 2016-03-01 Applied Biosystems, Llc SiRNA sequence-independent modification formats for reducing off-target phenotypic effects in RNAi, and stabilized forms thereof
US9284551B2 (en) 2007-09-19 2016-03-15 Applied Biosystems, Llc RNAi sequence-independent modification formats, and stabilized forms thereof

Also Published As

Publication number Publication date
AU2003273778A1 (en) 2004-05-04
EP1556510A2 (en) 2005-07-27
AU2003273778A8 (en) 2004-05-04
WO2004035819A3 (en) 2004-08-26
WO2004035819A2 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
Claes et al. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy
WO2004035819A8 (en) Oligonucleotide analogues for detecting and analyzing nucleic acids
WO2004053079A3 (en) Compositions, splice variants and methods relating to ovarian specific genes and proteins
WO2003012046A3 (en) Stk15 (stk6) gene polymorphism and methods of determining cancer risk
WO2008107134A3 (en) A method for detection of liver cancer, risk of liver cancer, risk of recurrence of liver cancer, malignancy of liver cancer and progression of liver cancer with time by using the methylated cytosine in basp1 gene and/or srd5a2 gene
WO2001077377A8 (en) Diagnosis of diseases associated with dna replication by assessing dna methylation
WO2003089897A3 (en) Diagnosis and treatment of vascular disease
US20110300535A1 (en) Method of identifying individuals at risk of thiopurine drug resistance and intolerance
WO2003014388A3 (en) Method and nucleic acids for the analysis of colon cancer
WO2003087763A3 (en) Association of polymorphisms in the sost gene region with bone mineral density
WO2003020118A3 (en) Diagnosis and treatment of vascular disease
Shen-Ong et al. Expression profiling identifies a novel α-methylacyl-CoA racemase exon with fumarate hydratase homology
WO2003054149A3 (en) Targeted genetic risk-stratification using microarrays
WO2008018789A3 (en) Methods and means for diagnosing and treatment of osteoarthritis
WO2003022875A3 (en) Polymorphisms of pd-1
Reiner et al. Restriction enzyme based enriched L1Hs sequencing (REBELseq): a scalable technique for detection of Ta subfamily L1Hs in the human genome
AU2003276727A1 (en) Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes
EP1662006A4 (en) Partially double stranded nucleic acid molecule
Kalinderi et al. No association of the Val158Met COMT polymorphism with Parkinson's disease in the Greek population
WO2006099329A3 (en) Method of analyzing breast cancer susceptibility and resistance
WO2003066877A3 (en) Compositions and methods relating to hepatic specific genes and proteins
WO2001020024A3 (en) Method for determining nucleic and/or amino acid sequences
TW200517502A (en) Methods for detecting Alzheimer's disease
WO2007134718A3 (en) Use of adamts4 gene and protein polymorphisms
DE60212930D1 (en) Detection method for target molecules, reagent and method for the detection of SNPs in DNA nucleotide sequences

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 18/2004 UNDER (72, 75) ADD "MARK, SÜREN (DK/DK); FENGERSVEJ 3 , DK-2500 VALBY (DK)"

CFP Corrected version of a pamphlet front page

Free format text: UNDER (54) PUBLISHED TITLE REPLACED BY CORRECT TITLE

WWE Wipo information: entry into national phase

Ref document number: 2003757735

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003757735

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP